{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:47:54Z","timestamp":1794430074088,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs, Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["526948"],"award-info":[{"award-number":["526948"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["181340"],"award-info":[{"award-number":["181340"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["156167"],"award-info":[{"award-number":["156167"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bank of Montreal Studentship in Medical Research at the Lunenfeld-Tanenbaum Research Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.1038\/s41388-026-03709-9","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:12:28Z","timestamp":1772856748000},"page":"1198-1210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CHD1 is a synthetic lethal vulnerability in MYC-driven breast cancer"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-5619","authenticated-orcid":false,"given":"Brandon","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8133-5459","authenticated-orcid":false,"given":"Linda Z.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-5556","authenticated-orcid":false,"given":"Miguel","family":"Ramalho-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"3709_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.19.1.1","volume":"19","author":"CV Dang","year":"1999","unstructured":"Dang CV. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. Mol Cell Biol. 1999;19:1\u201311.","journal-title":"Mol Cell Biol"},{"key":"3709_CR2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.celrep.2017.05.036","volume":"19","author":"M Percharde","year":"2017","unstructured":"Percharde M, Wong P, Ramalho-Santos M. Global Hypertranscription in the Mouse Embryonic Germline. Cell Rep. 2017;19:1987\u201396.","journal-title":"Cell Rep"},{"key":"3709_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41556-023-01212-x","volume":"25","author":"E Collignon","year":"2023","unstructured":"Collignon E, Cho B, Furlan G, Fothergill-Robinson J, Martin SB, McClymont SA, et al. m6A RNA methylation orchestrates transcriptional dormancy during paused pluripotency. Nat Cell Biol. 2023;25:1279\u201389.","journal-title":"Nat Cell Biol"},{"key":"3709_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","volume":"151","author":"Z Nie","year":"2012","unstructured":"Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, et al. c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells. Cell. 2012;151:68\u201379.","journal-title":"Cell"},{"key":"3709_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.diff.2010.05.001","volume":"80","author":"NV Varlakhanova","year":"2010","unstructured":"Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S, et al. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation. 2010;80:9\u201319.","journal-title":"Differentiation"},{"key":"3709_CR6","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.313104","volume":"18","author":"A Wilson","year":"2004","unstructured":"Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 2004;18:2747\u201363.","journal-title":"Genes Dev"},{"key":"3709_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","volume":"21","author":"C Lourenco","year":"2021","unstructured":"Lourenco C, Resetca D, Redel C, Lin P, MacDonald AS, Ciaccio R, et al. MYC protein interactors in gene transcription and cancer. Nat Rev Cancer. 2021;21:579\u201391.","journal-title":"Nat Rev Cancer"},{"key":"3709_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong Y, Tu R, Liu H, Qing G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct Target Ther. 2020;5:124.","journal-title":"Signal Transduct Target Ther"},{"key":"3709_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/genes8060151","volume":"8","author":"M Kalkat","year":"2017","unstructured":"Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, et al. MYC deregulation in primary human cancers. Genes. 2017;8:2\u201330.","journal-title":"Genes"},{"key":"3709_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102154","volume":"94","author":"MJ Duffy","year":"2021","unstructured":"Duffy MJ, O\u2019Grady S, Tang M, Crown J. MYC as a target for cancer treatment. Cancer Treat Rev. 2021;94:102154.","journal-title":"Cancer Treat Rev"},{"key":"3709_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01291-6","volume":"20","author":"SK Madden","year":"2021","unstructured":"Madden SK, de Araujo AD, Gerhardt M, Fairlie DP, Mason JM. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer. 2021;20:3.","journal-title":"Mol Cancer"},{"key":"3709_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tips.2020.11.014","volume":"42","author":"DKH Thng","year":"2021","unstructured":"Thng DKH, Toh TB, Chow EKH. Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age. Trends Pharm Sci. 2021;42:166\u201382.","journal-title":"Trends Pharm Sci"},{"key":"3709_CR13","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1101\/gad.244368.114","volume":"28","author":"CH Huang","year":"2014","unstructured":"Huang CH, Lujambio A, Zuber J, Tschaharganeh DF, Doran MG, Evans MJ, et al. CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. Genes Dev. 2014;28:1800\u201314.","journal-title":"Genes Dev"},{"key":"3709_CR14","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.1121119109","volume":"109","author":"M Toyoshima","year":"2012","unstructured":"Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci USA. 2012;109:9545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3709_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1084\/jem.20111512","volume":"209","author":"D Horiuchi","year":"2012","unstructured":"Horiuchi D, Kusdra L, Huskey NE, Chandriani S, Lenburg ME, Gonzalez-Angulo AM, et al. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J Exp Med. 2012;209:679\u201396.","journal-title":"J Exp Med"},{"key":"3709_CR16","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/j.molcel.2021.06.014","volume":"81","author":"JM Einstein","year":"2021","unstructured":"Einstein JM, Perelis M, Chaim IA, Meena JK, Nussbacher JK, Tankka AT, et al. Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer. Mol Cell. 2021;81:3048\u20133064.e9.","journal-title":"Mol Cell"},{"key":"3709_CR17","doi-asserted-by":"crossref","unstructured":"Sato M, Liebau RC, Liu Z, Liu L, Rabadan R, Gautier J. The UVSSA complex alleviates MYC-driven transcription stress. J Cell Biol. 2021;e201807163:220.","DOI":"10.1083\/jcb.201807163"},{"key":"3709_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.1212728","volume":"335","author":"JD Kessler","year":"2012","unstructured":"Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science. 2012;335:348\u201353. Jan 20.","journal-title":"Science"},{"key":"3709_CR19","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-22-2948","volume":"183","author":"P Lin","year":"2023","unstructured":"Lin P, Lourenco C, Cruickshank J, Palomero L, van Leeuwen JE, Tong AHY, et al. Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. Cancer Res. 2023;183:4015\u201329.","journal-title":"Cancer Res"},{"key":"3709_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nature08212","volume":"460","author":"A Gaspar-Maia","year":"2009","unstructured":"Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 2009;460:863\u20138.","journal-title":"Nature"},{"key":"3709_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1242\/dev.114843","volume":"142","author":"M Guzman-Ayala","year":"2015","unstructured":"Guzman-Ayala M, Sachs M, Koh FM, Onodera C, Bulut-Karslioglu A, Lin CJ, et al. Chd1 is essential for the high transcriptional output and rapid growth of the mouse epiblast. Development. 2015;142:118\u201327.","journal-title":"Development"},{"key":"3709_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25088-3","volume":"12","author":"A Bulut-Karslioglu","year":"2021","unstructured":"Bulut-Karslioglu A, Jin H, Kim YK, Cho B, Guzman-Ayala M, Williamson AJK, et al. Chd1 protects genome integrity at promoters to sustain hypertranscription in embryonic stem cells. Nat Commun. 2021;12:1\u201311.","journal-title":"Nat Commun"},{"key":"3709_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.02042","volume":"3","author":"PJ Skene","year":"2014","unstructured":"Skene PJ, Hernandez AE, Groudine M, Henikoff S. The nucleosomal barrier to promoter escape by RNA polymerase II is overcome by the chromatin remodeler Chd1. Elife. 2014;3:1\u201319.","journal-title":"Elife"},{"key":"3709_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molcel.2017.08.018","volume":"68","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, Levendosky RF, Chakravarthy S, Patel A, Bowman GD, Myong S. The Chd1 Chromatin Remodeler Shifts Nucleosomal DNA Bidirectionally as a Monomer. Mol Cell. 2017;68:76\u201388.e6.","journal-title":"Mol Cell"},{"key":"3709_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.09.010","volume":"143","author":"J Kim","year":"2010","unstructured":"Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, et al. A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs. Cell. 2010;143:313\u201324.","journal-title":"Cell"},{"key":"3709_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","volume":"133","author":"X Chen","year":"2008","unstructured":"Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008;133:1106\u201317.","journal-title":"Cell"},{"key":"3709_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111978","volume":"42","author":"YK Kim","year":"2023","unstructured":"Kim YK, Cho B, Cook DP, Trcka D, Wrana JL, Ramalho-Santos M. Absolute scaling of single-cell transcriptomes identifies pervasive hypertranscription in adult stem and progenitor cells. Cell Rep. 2023;42:111978.","journal-title":"Cell Rep"},{"key":"3709_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2016.11.010","volume":"40","author":"M Percharde","year":"2017","unstructured":"Percharde M, Bulut-Karslioglu A, Ramalho-Santos M. Hypertranscription in Development, Stem Cells, and Regeneration. Dev Cell. 2017;40:9\u201321.","journal-title":"Dev Cell"},{"key":"3709_CR29","doi-asserted-by":"publisher","first-page":"E1734","DOI":"10.1073\/pnas.1424850112","volume":"112","author":"FM Koh","year":"2015","unstructured":"Koh FM, Lizama CO, Wong P, Hawkins JS, Zovein AC, Ramalho-Santos M. Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription. Proc Natl Acad Sci. 2015;112:E1734\u201343.","journal-title":"Proc Natl Acad Sci"},{"key":"3709_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.stem.2018.02.004","volume":"22","author":"A Bulut-Karslioglu","year":"2018","unstructured":"Bulut-Karslioglu A, Macrae TA, Oses-Prieto JA, Covarrubias S, Percharde M, Ku G, et al. The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. Cell Stem Cell. 2018;22:369\u2013383.e8.","journal-title":"Cell Stem Cell"},{"key":"3709_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"3709_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"3709_CR33","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3709_CR34","doi-asserted-by":"crossref","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene Set Knowledge Discovery with Enrichr. Curr Protoc. 2021;1:e90.","DOI":"10.1002\/cpz1.90"},{"key":"3709_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 2013;14:128.","journal-title":"BMC Bioinforma"},{"key":"3709_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41592-020-0907-8","volume":"17","author":"A Sethi","year":"2020","unstructured":"Sethi A, Gu M, Gumusgoz E, Chan L, Yan KK, Rozowsky J, et al. Supervised enhancer prediction with epigenetic pattern recognition and targeted validation. Nat Methods. 2020;17:807\u201314.","journal-title":"Nat Methods"},{"key":"3709_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.038083","volume":"12","author":"C Lourenco","year":"2019","unstructured":"Lourenco C, Kalkat M, Houlahan KE, De Melo J, Longo J, Done SJ, et al. Modelling the MYC-driven normal-to-tumour switch in breast cancer. Dis Model Mech. 2019;12:1\u20139.","journal-title":"Dis Model Mech"},{"key":"3709_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3709_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41:211\u20138.","journal-title":"Trends Biochem Sci"},{"key":"3709_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou C, Gao Y, Ding P, Wu T, Ji G. The role of CXCL family members in different diseases. Cell Death Discov. 2023;9:212.","journal-title":"Cell Death Discov"},{"key":"3709_CR41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/jpm11070618","volume":"11","author":"C Mart\u00ednez-P\u00e9rez","year":"2021","unstructured":"Mart\u00ednez-P\u00e9rez C, Leung J, Kay C, Meehan J, Gray M, Dixon JM, et al. The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer. J Pers Med. 2021;11:618.","journal-title":"J Pers Med"},{"key":"3709_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami M, Kamimura D, Hirano T. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines. Immunity. 2019;50:812\u201331.","journal-title":"Immunity"},{"key":"3709_CR43","doi-asserted-by":"publisher","first-page":"32775","DOI":"10.18632\/oncotarget.25996","volume":"9","author":"AF Vega-Benedetti","year":"2018","unstructured":"Vega-Benedetti AF, Saucedo CN, Zavattari P, Vanni R, Royo F, Llavero F, et al. PLAGL1 gene function during hepatoma cells proliferation. Oncotarget. 2018;9:32775\u201394.","journal-title":"Oncotarget"},{"key":"3709_CR44","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.1073\/pnas.0406882102","volume":"102","author":"T Clouaire","year":"2005","unstructured":"Clouaire T, Roussigne M, Ecochard V, Mathe C, Amalric F, Girard JP. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci USA. 2005;102:6907\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3709_CR45","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/sj.onc.1206271","volume":"22","author":"M Roussigne","year":"2003","unstructured":"Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard JP. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene. 2003;22:2432\u201342.","journal-title":"Oncogene"},{"key":"3709_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1101\/gad.351979.124","volume":"39","author":"L Ataei","year":"2025","unstructured":"Ataei L, Zhang J, Monis S, Giemza K, Mittal K, Yang J, et al. LINE1 elements at distal junctions of rDNA repeats regulate nucleolar organization in human embryonic stem cells. Genes Dev. 2025;39:280\u201398.","journal-title":"Genes Dev"},{"key":"3709_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.15698\/cst2018.06.139","volume":"2","author":"K Yang","year":"2018","unstructured":"Yang K, Yang J, Yi J. Nucleolar stress: Hallmarks, sensing mechanism and diseases. Cell Stress. 2018;2:125\u201340.","journal-title":"Cell Stress"},{"key":"3709_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.devcel.2024.09.024","volume":"60","author":"J Zhang","year":"2025","unstructured":"Zhang J, Ataei L, Mittal K, Wu L, Caldwell L, Huynh L, et al. LINE1 and PRC2 control nucleolar organization and repression of the 8C state in human ESCs. Dev Cell. 2025;60:186\u2013203.","journal-title":"Dev Cell"},{"key":"3709_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88799","volume":"12","author":"TA Potapova","year":"2023","unstructured":"Potapova TA, Unruh JR, Conkright-Fincham J, Banks CA, Florens L, Schneider DA, et al. Distinct states of nucleolar stress induced by anticancer drugs. Elife. 2023;12:RP88799.","journal-title":"Elife"},{"key":"3709_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1101\/gad.349172.121","volume":"34","author":"SQ Xie","year":"2022","unstructured":"Xie SQ, Leeke BJ, Whilding C, Wagner RT, Garcia-Llagostera F, Low YX, et al. Nucleolar-based Dux repression is essential for embryonic two-cell stage exit. Genes Dev. 2022;34:331\u201347.","journal-title":"Genes Dev"},{"key":"3709_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/path.6292","volume":"263","author":"T Yeung","year":"2024","unstructured":"Yeung T, Zhang Y, Kennedy B, Walsh C, Love T, Xia D, et al. Multiplex imaging reveals spatially resolved DNA-damage response neighborhoods in TP53-mutated myelodysplastic neoplasms. J Pathol. 2024;263:386\u201395.","journal-title":"J Pathol"},{"key":"3709_CR52","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s43587-022-00263-3","volume":"2","author":"I Heckenbach","year":"2022","unstructured":"Heckenbach I, Mkrtchyan GV, Ezra MB, Bakula D, Madsen JS, Nielsen MH, et al. Nuclear morphology is a deep learning biomarker of cellular senescence. Nat Aging. 2022;2:742\u201355.","journal-title":"Nat Aging"},{"key":"3709_CR53","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1016\/j.cell.2024.10.035","volume":"187","author":"HF Noller","year":"2024","unstructured":"Noller HF. The ribosome comes to life. Cell. 2024;187:6486\u2013500.","journal-title":"Cell"},{"key":"3709_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","volume":"151","author":"CY Lin","year":"2012","unstructured":"Lin CY, Lov\u00e9n J, Rahl PB, Paranal RM, Burge CB, Bradner JE, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 2012;151:56\u201367.","journal-title":"Cell"},{"key":"3709_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201744754","volume":"19","author":"JB Heidelberger","year":"2018","unstructured":"Heidelberger JB, Voigt A, Borisova ME, Petrosino G, Ruf S, Wagner SA, et al. Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. EMBO Rep. 2018;19:1\u201320.","journal-title":"EMBO Rep"},{"key":"3709_CR56","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.molcel.2024.10.006","volume":"84","author":"SK Das","year":"2024","unstructured":"Das SK, Karmakar S, Venkatachalapathy H, Jha RK, Batchelor E, Levens D. Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome. Mol Cell. 2024;84:4059\u20134078.e10.","journal-title":"Mol Cell"},{"key":"3709_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molcel.2021.11.016","volume":"82","author":"SK Das","year":"2022","unstructured":"Das SK, Kuzin V, Cameron DP, Sanford S, Jha RK, Nie Z, et al. MYC assembles and stimulates topoisomerases 1 and 2 in a \u2018topoisome. Mol Cell. 2022;82:140\u2013158.e12.","journal-title":"Mol Cell"},{"key":"3709_CR58","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1128\/MCB.15.5.2745","volume":"15","author":"DG Stokes","year":"1995","unstructured":"Stokes DG, Perry RP. DNA-Binding and Chromatin Localization Properties of CHD1. Mol Cell Biol. 1995;15:2745\u201353.","journal-title":"Mol Cell Biol"},{"key":"3709_CR59","doi-asserted-by":"publisher","first-page":"20056","DOI":"10.1021\/acs.jmedchem.4c01172","volume":"67","author":"RL Johnson","year":"2024","unstructured":"Johnson RL, Graboski AL, Li F, Norris-Drouin JL, Walton WG, Arrowsmith CH, et al. Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer. J Med Chem. 2024;67:20056\u201375.","journal-title":"J Med Chem"},{"key":"3709_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3644","volume":"16","author":"S Tan","year":"2014","unstructured":"Tan S, Ding K, Li R, Zhang W, Li G, Kong X, et al. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res. 2014;16:1\u201313.","journal-title":"Breast Cancer Res"},{"key":"3709_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2005.12.016","volume":"21","author":"ASL Cheng","year":"2006","unstructured":"Cheng ASL, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, et al. Combinatorial Analysis of Transcription Factor Partners Reveals Recruitment of c-MYC to Estrogen Receptor-\u03b1 Responsive Promoters. Mol Cell. 2006;21:393\u2013404.","journal-title":"Mol Cell"},{"key":"3709_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature21357","volume":"542","author":"D Zhao","year":"2017","unstructured":"Zhao D, Lu X, Wang G, Lan Z, Liao W, Li J, et al. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature. 2017;542:484\u20138.","journal-title":"Nature"},{"key":"3709_CR63","doi-asserted-by":"publisher","first-page":"E1724","DOI":"10.1073\/pnas.1415569112","volume":"112","author":"B Yu","year":"2015","unstructured":"Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee CS, et al. Oncogenesis driven by the Ras\/Raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci USA. 2015;112:E1724\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3709_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1743-422X-11-180","volume":"11","author":"MJ Rodgers","year":"2014","unstructured":"Rodgers MJ, Banks DJ, Bradley KA, Young JA. CHD1 and CHD2 are positive regulators of HIV-1 gene expression. Virol J. 2014;11:180.","journal-title":"Virol J"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03709-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:12:27Z","timestamp":1774307547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03709-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":64,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,4,14]]}},"alternative-id":["3709"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03709-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.08.14.670376","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal procedures were approved by the UHN Animal Resources Centre in compliance with the Canadian Council on Animal Care guidelines under the Animal Use Protocol (AUP972.35). No human subjects were involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}